https://www.jpmh.org/index.php/jpmh/issue/view/116/70
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] / Calabrò, G.E., Boccalini, S., Bechini, A., Panatto, D., Domnich, A., Lai, P.L., Amicizia, D., Rizzo, C., Pugliese, A., DI Pietro, M.L., Zanella, B., Parente, F., Trombetta, C.S., Saraceno, G., Sottile, S., Abreha, F.M., Giacchetta, I., Properzi, S., Santolini, G., D'Ambrosio, F., et al.. - In: JOURNAL OF PREVENTIVE MEDICINE AND HYGIENE. - ISSN 2421-4248. - ELETTRONICO. - 63:(2022), pp. E1-E140. [10.15167/2421-4248/jpmh2022.63.4s1]
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0]
Boccalini, Sara;Bechini, Angela;Zanella, Beatrice;Bonanni, Paolo;
2022
Abstract
https://www.jpmh.org/index.php/jpmh/issue/view/116/70| File | Dimensione | Formato | |
|---|---|---|---|
|
116-94-PB.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
7.69 MB
Formato
Adobe PDF
|
7.69 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



